Optimizing the treatment of atopic dermatitis in children: A review of the benefit/risk ratio of methylprednisolone aceponate

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 5, 2011, Pages 508-515

  Blume Peytavi, U ^a   Wahn, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

atopic dermatitis; calcineurin inhibitors; methylprednisolone aceponate; MPA; therapeutic index

Indexed keywords

ACLOMETASONE; ANTIHISTAMINIC AGENT; AZATHIOPRINE; BETAMETHASONE VALERATE; BUDESONIDE; CALCINEURIN INHIBITOR; CLOBETASONE BUTYRATE; CORTICOSTEROID; CYCLOSPORIN A; EMOLLIENT AGENT; FLUTICASONE PROPIONATE; HYDROCORTISONE 17 BUTYRATE 21 PROPIONATE; HYDROCORTISONE ACEPONATE; HYDROCORTISONE ACETATE; HYDROCORTISONE BUTYRATE; METHYLPREDNISOLONE ACEPONATE; MOMETASONE FUROATE; PIMECROLIMUS; PREDNICARBATE; TACROLIMUS; UNCLASSIFIED DRUG;

ATOPIC DERMATITIS; BODY SURFACE; CHILD CARE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFORMATIONAL TRANSITION; CREAM; CUSHING SYNDROME; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; DRUG STRUCTURE; GROWTH DISORDER; HUMAN; LONG TERM CARE; LYMPHOMA; MAINTENANCE THERAPY; MILK; OINTMENT; ONSET AGE; PHOTOTHERAPY; PRIORITY JOURNAL; PUVA; REVIEW; RISK BENEFIT ANALYSIS; SKIN CANCER; SKIN INFECTION;

EID: 79954605530     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03942.x     Document Type: Review

References (56)

1. National Institute for Clinical Excellence. Clinical Guideline 57. Management of Atopic Eczema in Children from Birth Up To the Age of 12 Years. NICE, London, UK, 2007.
2. Casaño ÚV, Cavallé JR,. The milk formulation in topical corticotherapy: outcomes in children with atopic dermatitis. Monografía de Dermatología 2002; XV: 399-408.
3. Korotky NG, Taganov AV, Shimanovsky NL,. Use of Advantan in the treatment of atopic dermatitis in children. Pediatriya 2000; 5: 75-78.
4. Bergmann RL, Edenharter G, Bergmann KE, et al. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 1998; 28: 965-970. (Pubitemid 28401835)
5. Hopkin JM,. Mechanisms of enhanced prevalence of asthma and atopy in developed countries. Curr Opin Immunol 1997; 9: 788-792. (Pubitemid 28062261)
6. Cookson WO, Ubhi B, Lawrence R, et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 2001; 27: 372-373. (Pubitemid 32268416)
7. Eichenfield LF, Hanifin JM, Beck LA, et al. Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics 2003; 111: 608-616. (Pubitemid 36330720)
8. Illi S, von ME, Lau S, Niggemann B, Grüber C, Wahn U,. Perennial allergen sensitization early in life and chronic asthma in children: a birth cohort study. Lancet 2006; 368: 763-770. (Pubitemid 44279054)
9. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD,. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 162: 403-406.
10. Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349: 1414-1422. (Pubitemid 37211056)
11. Nickel R, Kulig M, Forster J, et al. Sensitization to hen's egg at the age of twelve months is predictive for allergic sensitisation to common indoor and outdoor allergens at the age of three years. J Allergy Clin Immunol 1997; 99: 613-617. (Pubitemid 27213187)
12. Bacharier LB, Boner A, Carlsen K-H, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008; 63: 5-34. (Pubitemid 350198248)
13. Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2006; 118: 152-169. (Pubitemid 43946480)
14. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis. J Am Acad Dermatol 2004; 50: 391-404. (Pubitemid 38324578)
15. West DP, Worobec S, Solomon LM,. Pharmacology and toxicology of infant skin. J Invest Dermatol 1981; 76: 147-150. (Pubitemid 11114058)
16. Heinmann G,. Enteral absorption and biovailability in children in relation to age. Eur J Clin Pharmacol 1980; 18: 43-50.
17. Turpeinen M,. Influence of age and severity of dermatitis on the percutaneous absorption of hydrocortisone in children. Br J Dermatol 1988; 118: 517-522.
18. Fischer G,. Compliance problems in paediatric atopic eczema. Australas J Dermatol 1996; 37 (Suppl 1): S10-S13. (Pubitemid 126443314)
19. Daniels R, Knie U,. Galenics of dermal products-vehicles, properties and drug release. J Dtsch Dermatol Ges 2007; 5: 367-383. (Pubitemid 46648932)
20. Mori M, Pimpinelli N, Giannotti B,. Topical corticosteroids and unwanted local effects-improving the benefit/risk ratio. Drug Saf 1994; 10: 406-412. (Pubitemid 24141350)
21. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ,. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006; 54: 1-15.
22. Kaufmann R, Fölster-Holst R, Höger P, et al. Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants. J Allergy Clin Immunol 2004; 114: 1183-1188. (Pubitemid 39469163)
23. Stabb D, Pariser D, Gottlieb AB, et al. Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis-a multicenter, 3-week, open-label study. Pediatr Dermatol 2005; 22: 465-471. (Pubitemid 43961008)
24. Reitamo S, Rustin M, Ruzicka T, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 539-546. (Pubitemid 34234208)
25. Wahn U, Bos JD, Goodfield M, et al. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 2002; 110 (1 pt 1): e2.
26. Papp K, Staab D, Harper J, et al. Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis. Int J Dermatol 2004; 43: 978-983. (Pubitemid 39642340)
27. Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC,. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta analysis of randomised controlled trials. BMJ 2005; 330: 516.
28. Reitamo S, Harper J, Bos JD, et al. 0.03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis. Results of a randomized, double-blind, controlled trial. Br J Dermatol 2004; 150: 554-562. (Pubitemid 38446313)
29. Arkwright PD, Gillespie MC, Ewing CI, David TJ,. Blinded side-to-side comparison of topical corticosteroid and tacrolimus ointment in children with moderate to severe atopic dermatitis. Clin Exp Dermatol 2007; 32: 145-147. (Pubitemid 46233015)
30. Reitamo S, Mandelin J, Rubens A, et al. The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis. Int J Dermatol 2009; 48: 348-355.
31. Remitz A, Reitamo S,. Long-term safety of tacrolimus ointment in atopic dermatitis. Expert Opin Drug Saf 2009; 8: 501-506.
32. Schneeweiss S, Doherty M, Zhu S, et al. Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma. Dermatology 2009; 219: 7-21.
33. Crespi HG,. Topical corticosteroid therapy for children: alclometasone dipropionate cream 0.05%. Clin Ther 1986; 8: 203-210. (Pubitemid 17074644)
34. Lassus J,. Clinical comparison of alclometasone dipropionate cream 0.05% with hydrocortisone butyrate cream 0.1% in the treatment of atopic dermatitis in children. Int Med Res 1983; 11: 315-319.
35. Lassus J,. Alclometasone dipropionate cream 0.05% versus clobetasone butyrate cream 0.05%. A controlled clinical comparison in the treatment of atopic dermatitis in children. Int J Dermatol 1984; 23: 565-566.
36. Wolkerstorfer A, Strobos MA, Glazenburg EJ, Mulder PG, Oranje AP,. Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis. J Am Acad Dermatol 1998; 39: 226-231. (Pubitemid 28367334)
37. Rafanelli A, Rafanelli S, Stanganelli I, et al. Mometasone furoate in the treatment of atopic dermatitis in children. J Eur Acad Dermatol Venereol 1993; 2: 225-230. (Pubitemid 23288147)
38. Hanifin J, Gupta AK, Rajagopalan R,. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br J Dermatol 2002; 147: 528-537. (Pubitemid 35015290)
39. Glazenburg EJ, Wolkerstorfer A, Gerretsen AL, Mulder PG, Oranje AP,. Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls? Pediatr Allergy Immunol 2009; 20: 59-66.
40. Peserico A, Städtler G, Sebastian M, Suarez Fernandez R, Vick K, Bieber T,. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: A multicenter, randomized, double-blind, controlled study. Br J Dermatol 2008; 158: 801-807. (Pubitemid 351415740)
41. Hebert AA, Friedlander SF, Allen DB,. Topical fluticasone propionate lotion does not cause HPA axis suppression. J Pediatr 2006; 149: 378-382. (Pubitemid 44308433)
42. Friedlander SF, Hebert AA, Allen DB,. Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months. J Am Acad Dermatol 2002; 46: 387-393. (Pubitemid 34225403)
43. Rampini E,. Methylprednisolone aceponate (MPA)-use and clinical experience in children. J Dermatol Treat 1992; 3 (Suppl 2): 27-29. (Pubitemid 23016831)
44. Gupta AK, Chow M,. A review of prednicarbate (Dermatop). Skin Therapy Lett 2004; 9: 5-6, 9.
45. Spencer CM, Wagstaff AJ,. Prednicarbate: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. BioDrugs 1998; 9: 61-86. (Pubitemid 28053765)
46. Kirkup ME, Birchall NM, Weinberg EG, Helm K, Kennedy CT,. Acute and maintenance treatment of atopic dermatitis in children-two comparative studies with fluticasone propionate (0.05%) cream. J Dermatolog Treat 2003; 14: 141-148. (Pubitemid 37254625)
47. Täuber U,. Pharmacokinetics and bioactivation of MPA. JEADV 1994; 3 (Suppl 1): 23-31.
48. Bieber T, Vick K, Fölster-Holst R, et al. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy 2007; 62: 184-189. (Pubitemid 46090301)
49. Alchorne MM, Cestari S da CP, Pereira SM, et al. A multicentre, comparative, open-labelled, randomized study of tolerability and efficacy of methylprednisolone aceponate and mometasone furoate in children from 2 to 14 years of age suffering from atopic dermatitis. Pediatria Moderna 2003; XXXIX: 275-280.
50. Ortonne JP,. Safety aspects of topical methylprednisolone aceponate (MPA) treatment. J Dermatol Treat 1992; 3 (Suppl 2): 21-25.
51. Grebenyuk VN, Balabolkin II,. Progress in topical corticosteroid therapy of atopic dermatitis in children. Pediatriya 1998; 5: 88-91.
52. Niedner R, Zaumseil R-P,. Advantan milk/cream.ointment in children with atopic dermatitis and other inflammatory or eczematous dermatoses-an observational study in 558 children. Akt Dermatol 2004; 30: 200-203. (Pubitemid 38886442)
53. Szczepanowska J, Reich A, Szepietowski JC,. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study. Pediatr Allergy Immunol 2008; 19: 614-618.
54. ®)-an effective topical corticoid therapy with few side effects. In, Macher E, Kolde G, Bröcker EB, eds. Jahrbuch der Dermatologie 1992/93. Blermann Verlag, Zülpich, Germany, 199293: 247-263.
55. Mensing H, Lorenz B,. Experience with methylprednisolone aceponate (MPA) in patients suffering from acute and chronic eczema. Results of a large observational study. Z Hautkr 1998; 73: 281-285.
56. Kungurov NV, Kokhan MM, Keniksfest JV, et al. Difference topical therapy of the atopic eczema in children and adults. Abstract #P2-3. JEADV 2001; 15 (Suppl 2): 104-274.